There is a need to refine our current psychiatric nosology to produce diagnostic criteria and disorder categories that keep pace with advances in neuroscience while at the same time enhance clinical utility. Furthermore, dimensional aspects of psychiatric disorders require greater recognition so as to improve our understanding of boundaries between disorders and underscore the heterogeneous nature of psychopathology. The Conceptual Evolution of DSM-5
provides a framework for the evolution of the forthcoming diagnostic system in the fifth edition of Diagnostic and Statistical Manual of Mental Disorders
(DSM-5), which will help advance clinical practice and facilitate ongoing development of diagnostic criteria. This manual:
- Highlights recent progress in our understanding of cross-cutting factors relevant to psychiatric diagnosis and symptom presentation
- Includes detailed discussions on the role of factors such as age, gender, culture, and disability in the expression of mental disorders
- Provides a review of genetic evidence supporting a cross-cutting approach to nosology
- Offers suggestions for integrating cross-cutting factors with DSM-5.
The Conceptual Evolution of DSM-5 was written to impart a theoretical context for understanding potential revisions to DSM-5. The authors reevaluate the structure of the current manual and discuss cross-cutting approaches to facilitate clinical practice and refine research approaches that will guide clinical trials, genetics, imaging, and treatment guidelines. The authors provide the following insights:
- Detailed descriptions of age-, gender-, and culture-specific aspects relevant to psychiatric diagnosis and the need for sensitivity to these factors when making diagnoses
- Discussions on the dimensional aspects of mental disorders, including overlapping symptoms relevant to many or most diagnoses
- Consideration of alternative classifications of disorders that recognize disorders sharing validating features
- Presentation of neuroscientific and epidemiologic evidence to expand understanding of disorders beyond that of the categorical organization presented in DSM-IV
- A review of clinical implications, including how clinicians may shift their conceptualization of previously reified diagnostic criteria and their consequences.
As presented to the 99th Annual Meeting of the American Psychopathological Association, The Conceptual Evolution of DSM-5 explores the rapidly changing research base for the understanding of neurodevelopmental, neurocognitive, addictive, and other psychiatric disorders. The contributions in this volume confirm that DSM-5 is intended to be a living document that can accommodate revisions to specific diagnostic areas based on new evidence that is replicable and subject to review. This efficient updating process will help researchers and clinicians keep abreast of the latest protocols for the research, diagnosis, and treatment of mental illness.
Introduction. Part I: Diagnostic Spectra: Assessing the Validity of Disorder Groupings. Diagnosis of mental disorders in light of modern genetics. Integration of dimensional spectra for depression and anxiety into categorical diagnoses for general medical practice. One way forward for psychiatric nomenclature: the example of the spectrum project approach. Meta effects of classifying mental disorders. Part II: Integrating Dimensional Concepts Into a Categorical System. A proposal for incorporating clinically relevant dimensions into DSM-5. Empirically derived personality disorder prototypes: bridging dimensions and categories in DSM-5. Options and dilemmas of dimensional measures for DSM-5: which types of measures fare best in predicting course and outcome? Part III: Assessing Functional Impairment for Clinical Significance and Disability. Clinical significance and disorder thresholds in DSM-5: the role of disability and distress. Assessing activity limitations and disability among adults. Measuring disability across physical, mental, and cognitive disorders. Part IV: Identifying Important Culture- and Gender-Related Expressions of Disorders. Assessing mental disorders and service use across countries: the WHO World Mental Health Survey Initiative. The intersection of race, ethnicity, immigration, and cultural influences on the nature and distribution of mental disorders: an examination of major depression. Gender and gender-related issues in DSM-5. Part V: Incorporating Developmental Variations of Disorder Expression Across the Lifespan. Increasing the developmental focus in DSM-5: broad issues and specific potential applications in anxiety. Diagnostic issues relating to lifespan from adulthood into later life. Index.
"This volume provides a snapshot of the progress and the uncertainties of psychiatric classification and diagnosis at the end of the first decade of the new millennium. The reader is likely to perceive that a paradigm shift is upcoming, although the connotates of this shift are still unclear. He will probably get a sense of excitement mixed with agoraphobia, which is the best our times are able to offer in this area."—Mario Maj, M.D., Professor of Psychiatry and Chairmen, Department of Psychiatry, University of Naples SUN
"This is a superb volume with provocative and engaging chapters from many of the thought leaders in psychiatric nosology. It gives rare insight into the issues under consideration as a new nomenclature was still under development, and the varying perspectives on these issues. I would recommend it to any user of DSM-V who wants to deepen their understanding of the final product."—Ezra Susser, Professor of Epidemiology and Psychiatry, Columbia, University, Mailman School of Public Health, New York State, Psychiatric Institute
"This is a superb overview of the concepts and logic underlying DSM-5.The authors are outstanding clinical scientists who have been strongly involved in the development of an updated diagnostic system for mental disorders.The need to re-think current psychiatric classification is clear in light of major problems with indistinct categories, numerous co-morbidities, complex and overlapping genetics, and shared neural circuitry.Only time and systematic follow-up studies will tell whether the approaches to diagnosis outlined in this thoughtful and provocative text, including the consideration of dimensional diagnostic approaches, will enhance our ability to validate and understand these complex illnesses."—Charles F. Zorumski, M.D., Samuel B. Guze Professor and Head of Psychiatry,Professor of Neurobiology, Washington University School of Medicine, St. Louis MO
J�ri Allik, Ph.D.
Michael Ashton, Ph.D.
Carl C. Bell, M.D.
Lee Anna Clark, Ph.D.
C. Robert Cloninger, M.D.
Paul Costa Jr., Ph.D.
Barbara De Clercq, Ph.D.
Filip De Fruyt, Ph.D.
Yueqin Huang, M.D., M.P.H., Ph.D.
Robert F. Krueger, Ph.D.
W. John Livesley, M.D., Ph.D.
Juan J. L�pez-Ibor, M.D.
Peter McGuffin, M.D., Ph.D.
Ivan Mervielde, Ph.D.
John M. Oldham, M.D.
Joel Paris, M.D.
Charles B. Pull, M.D., Ph.D.
M. Tracie Shea, Ph.D.
Rebecca L. Shiner, Ph.D.
Erik Simonsen, M.D.
Paul J. Sirovatka, M.S.
Siu Wa Tang, M.B., Ph.D., F.R.C.P.(C.)
Timothy J. Trull, Ph.D.
Peter Tyrer, M.D.
Karla Van Leeuwen, Ph.D.
Roel Verheul, Ph.D.
David Watson, Ph.D.
Drew Westen, Ph.D.
Thomas A. Widiger, Ph.D.
Theresa Wilberg, M.D., Ph.D.
Darrel A. Regier, M.D., M.P.H.,
is Executive Director of the American Psychiatric Institute for Research and Education and Director of the Division of Research at the American Psychiatric Association in Arlington, Virginia, and Vice-Chair of the DSM-5 Task Force.
William E. Narrow, M.D., M.P.H., is Associate Director of the Division of Research at the American Psychiatric Association and the American Psychiatric Institute for Research and Education in Arlington, Virginia, and Research Director of the DSM-5 Task Force.
Emily A. Kuhl, Ph.D., is a science writer in the Division of Research at the American Psychiatric Association in Arlington, Virginia.
David J. Kupfer, M.D., is Thomas Detre Professor in the Department of Psychiatry at the University of Pittsburgh and Western Psychiatric Institute & Clinic in Pittsburgh, Pennsylvania, and Chair of the DSM-5 Task Force.